Topical Collection on Chronic Lymphocytic Leukemias

ISSN: 1558-8211 (Print) 1558-822X (Online)

In this topical collection (24 articles)

previous disabled Page of 2

  1. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

    Benjamin L. Lampson, Matthew S. Davids Pages 11-19

  2. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)

    Erin M. Pettijohn, Shuo Ma Pages 20-28

  3. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia

    Mazie Tsang, Sameer A. Parikh Pages 29-38

  4. Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

    Ciara L. Freeman, John G. Gribben Pages 29-36
    Download PDF (433KB) View Article

  5. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Prognostic Factors for Chronic Lymphocytic Leukemia

    Christopher Chen, Soham Puvvada Pages 37-42

  6. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies

    Michael Rainone, Tanya Siddiqi Pages 39-45

  7. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Richter Syndrome in Chronic Lymphocytic Leukemia

    Candida Vitale, Alessandra Ferrajoli Pages 43-51

  8. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents

    Joseph Maly, James S. Blachly Pages 52-60

  9. No Access

    Chronic Lymphocytic Leukemias (S O’Brien, Section Editor)

    Where Does Allogeneic Stem Cell Transplantation Fit in the Treatment of Chronic Lymphocytic Leukemia?

    Peter Dreger, Emili Montserrat Pages 59-64

  10. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting

    Spencer H. Bachow, Nicole Lamanna Pages 61-70

  11. No Access

    ReviewPaper

    Frontline Therapy of CLL—Changing Treatment Paradigms

    Catherine C. Coombs Pages 65-74

  12. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Frontline Therapy of CLL: Evolving Treatment Paradigm

    Craig S. Boddy, Shuo Ma Pages 69-77

  13. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Is There a Role for Chemotherapy in the Era of Targeted Therapies?

    Jason C. Lee, Nicole Lamanna Pages 72-82

  14. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Prognostic Factors in the Era of Targeted Therapies in CLL

    Prajwal Boddu, Alessandra Ferrajoli Pages 78-90

  15. ReviewPaper

    Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

    Oluwatobi Odetola, Shuo Ma Pages 130-143
    Download PDF (1187KB) View Article

  16. No Access

    ReviewPaper

    Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?

    Hadiyah Y. Audil, Samuel R. Kosydar… Pages 144-157

  17. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editors)

    Frontline Therapy of Chronic Lymphocytic Leukemia: Changing Treatment Paradigm

    Manju Sengar, Hasmukh Jain, Akhil Rajendra… Pages 168-176

  18. No Access

    ReviewPaper

    Targeting BTK in CLL: Beyond Ibrutinib

    David A. Bond, Jennifer A. Woyach Pages 197-205

  19. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia

    Krish Patel, John M. Pagel Pages 292-301

  20. No Access

    Chronic Lymphocytic Leukemias (N Jain, Section Editor)

    Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL

    Adam S. Kittai, Matthew Lunning… Pages 302-309
previous disabled Page of 2